Research Article
GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
Table 2
Univariate and multivariate Cox regression analysis of the GABPA expression and overall survival in EC patients.
| | Variable | Univariable | Multivariable | | HR (95% CI) | value | HR (95% CI) | value |
| | Age (<60 vs ≥60) | 1.747 (0.827-3.692) | 0.144 | — | 0.215 | | Histology (type I vs type II) | 2.237 (1.152-4.343) | 0.017 | — | 0.411 | | Grade (G1-2 vs G3) | 2.933 (1.344-6.401) | 0.007 | 2.381 (1.068-5.310) | 0.034 | | Stage (stage I vs stage II-IV)) | 3.387 (1.935-7.607) | ≤0.001 | 3.033 (1.505-6.123) | 0.002 | | Surgical (open vs mini-invasive) | 0.671 (0.313-1.436) | 0.304 | | | | GABPA (low vs high) | 0.487 (0.246-0.966) | 0.040 | 0.491 (0.246-0.977) | 0.043 |
|
|
GABPA: GA-binding protein A; EC: endometrial carcinoma; age: age of endometria carcinoma diagnosis; HR: hazard ratio; CI: confidence interval; bold type and ( ) indicate statistical significance. |